As of 2025-07-03, the Intrinsic Value of Rentokil Initial PLC (RTO.L) is 217.61 GBP. This RTO.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 353.60 GBP, the upside of Rentokil Initial PLC is -38.50%.
The range of the Intrinsic Value is 124.37 - 443.03 GBP
Based on its market price of 353.60 GBP and our intrinsic valuation, Rentokil Initial PLC (RTO.L) is overvalued by 38.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 124.37 - 443.03 | 217.61 | -38.5% |
| DCF (Growth 10y) | 175.41 - 526.48 | 279.00 | -21.1% |
| DCF (EBITDA 5y) | 91.23 - 139.02 | 111.31 | -68.5% |
| DCF (EBITDA 10y) | 138.52 - 210.40 | 169.41 | -52.1% |
| Fair Value | 101.67 - 101.67 | 101.67 | -71.25% |
| P/E | 170.66 - 249.31 | 220.57 | -37.6% |
| EV/EBITDA | 123.70 - 232.49 | 169.98 | -51.9% |
| EPV | 527.12 - 744.80 | 635.96 | 79.9% |
| DDM - Stable | 92.10 - 235.96 | 164.03 | -53.6% |
| DDM - Multi | 156.90 - 291.12 | 201.94 | -42.9% |
| Market Cap (mil) | 8,549.09 |
| Beta | 0.95 |
| Outstanding shares (mil) | 24.18 |
| Enterprise Value (mil) | 11,733.09 |
| Market risk premium | 5.98% |
| Cost of Equity | 10.25% |
| Cost of Debt | 4.87% |
| WACC | 8.19% |